Aulos Bioscience Begins Phase 2 Dosing of AU-007 and Nivolumab Combo for Melanoma Immuno-oncology innovator Aulos Bioscience has initiated dosing in a new cohort of its ongoing Phase 1/2 clinical trial, marking a significant step forward in the development of…
Bruker Enhances IR Biotyper® for Hospital Hygiene with NGS Reflex Testing At the ESCMID Global 2025 conference, Bruker’s Microbiology and Infection Diagnostics division made a major announcement regarding the expansion of its microbiology solutions to include Next-Generation Sequencing (NGS) applications.…
Amneal Pharmaceuticals Commits $1.5 Million to Support Parkinson’s Disease Patients During Awareness Month In a powerful show of solidarity with the Parkinson’s community, Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), a global biopharmaceutical company dedicated to improving lives through the development and…
Avanzanite Bioscience Appoints Sotiris Botozis as Managing Director for Southern Europe Amid Strategic Expansion and Unprecedented Growth Avanzanite Bioscience BV, a rapidly growing player in the European life sciences and orphan drug commercialization landscape, has announced the appointment of Sotiris…
Survey: Americans Shocked by Rx Costs, Few Talk to Pharmacists A recent nationwide survey conducted by Lumicera Health Services— the specialty pharmacy arm of Navitus Health Solutions—has unveiled a paradox at the heart of the U.S. healthcare system. While Americans…
California Advocates Urge Greater Access to Plasma-Derived Medicines In a compelling call to action, the California Rare Disease Access Coalition, Hemophilia Council of California, and the Plasma Protein Therapeutics Association (PPTA) have joined forces to advocate for the swift passage…
Unlearn Appoints Krates Ng as Chief Technology Officer to Lead Next Phase of Technological and Operational Expansion Unlearn®, a pioneer in developing artificial intelligence solutions to optimize clinical trials, has announced the appointment of Krates Ng as its Chief Technology…
Guardian Pharmacy Services Expands LTC Reach with Naples Pharmacy Acquisition Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the largest and most forward-thinking long-term care (LTC) pharmacy providers in the United States, has announced a major strategic expansion with the…
Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses In a major step toward transforming the landscape of vaccine development and delivery, Ethris, a clinical-stage biotechnology company leading innovation in RNA therapeutics and vaccines, has announced a…
Avenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market Avenacy Launches FDA-Approved Propofol Injectable Emulsion, USP in the United States: A Milestone in Critical Care and Anesthesia Access Avenacy, a rising force in the specialty pharmaceutical sector, announced today…
Flatiron Health Partners with Massive Bio to Strengthen Patient Identification and Services In a strategic move poised to reshape the landscape of oncology clinical research, Flatiron Health, a leading health technology company dedicated to transforming clinical trials through the integration…
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company focused on the development and commercialization of precision oncology therapies, today announced that…